Bioindustrial Manufacturing
Bioindustrial Manufacturing
Unlocking AV and AAV Manufacturing Secrets with Analytics
1. 🔍 Robust processing and advanced analytics are vital for consistent quality in viral vector manufacturing. 🧬 iCELLis simplifies downstream processing. 2. Analytics Key to AV and AAV Manufacturing 🔍 Robust processing and advanced analytics are vital for consistent product quality in viral vector manufacturing. 🧬 Scaling up requires comparability studies and iCELLis simplifies downstream processing. Analytical methods like ELISA, PCR, and light scattering are essential for process optimization. Challenges include removing empty capsids and adapting process analytic technology.
Novo Nordisk’s Massive Expansion in USA: Manufacturing Innovation for Obesity and Chronic Diseases!
Novo Nordisk's massive expansion in Clayton, NC will boost local economy and create life-saving treatments for chronic diseases. 🏭💊📈
Breakthrough: Safer and Cheaper Alternative to Viral Vectors
📰 Overcoming Viral Vector Risks explores the limitations & risks of viral vectors in CGT manufacturing. ⚠️ FDA warnings & a safer alternative: electroporation. 💡
Novo Nordisk’s $41B Plant Expansion Creates 1000 Jobs and Meets Growing Demand
🏭 Novo Nordisk is building a $4.1B plant in Clayton, NC, creating 1,000 jobs and expanding manufacturing space. 💉💼
Revolutionary Partnership Turbocharges Biopharma Drug Development
🔍 Abzena and Argonaut partner to offer drug development and manufacturing support for biopharma companies. 💊🤝🚀💪👥
Unlocking Advanced Therapy’s Potential with AI: The Key Ingredients
🌍 Advanced therapy manufacturers must have robust hardware and monitoring software in place before benefiting from AI. 🤖📈
Revolutionary Approach to Manufacturing Macrophages
🧪💡✨ Meeting the Challenge of Manufacturing Macrophages explores how Resolution Therapeutics overcomes obstacles to produce effective macrophage therapy.
WuXi Biologics Supercharges Manufacturing with 5000L Bioreactors!
⚡ WuXi Biologics upgrades manufacturing capability with installation of three 5,000L single-use bioreactors! 🏭✨🔝
Revolutionary Genomic Tech Promises Cheaper Animal Vaccines
📅 June 3, 2024: High costs and technical difficulties limit animal vaccine development. 💉 New QTL technology offers affordable and effective vaccines. 🔬🚀
Revolutionary Cell Therapy Platform: Faster Cheaper and Automated!
🚀 Cytiva launches Sefia platform, speeding up cell-based treatments production. 💉 Sefia lowers costs, reduces errors, and saves time. 🔬 Scalable and flexible for all manufacturing stages. 💼 Direct marketing to customers.
